SULT2B1 and obesity disorder: Taken together, our results demonstrated that the ablation of Sult2b1 inhibits intestinal lipid absorption potentially by interfering with lipoprotein assembly, which leads to the decrease of systemic fatty acid level and ameliorates obesity.